CCP
CLVS

Clough Capital Partners’s Clovis Oncology, Inc. CLVS Stock Holding History

Clough Capital Partners’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-106,335
Closed -$5.61M – 161
2018
Q1 		$5.61M Sell
106,335
-47,400
-31% -$2.77M 0.54% 58
2017
Q4 		$10.5M Buy
153,735
+70,000
+84% +$4.89M 0.87% 39
2017
Q3 		$6.9M Buy
83,735
+73,200
+695% +$5.8M 0.46% 57
2017
Q2 		$986K Sell
10,535
-5,365
-34% -$328K 0.07% 99
2017
Q1 		$1.01M Buy
15,900
+100
+0.6% +$6.08K 0.06% 104
2016
Q4 		$702K Sell
15,800
-11,700
-43% -$412K 0.05% 132
2016
Q3 		$991K Buy
+27,500
New +$590K 0.05% 135

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Clough Capital Partners's CLVS Position: Q2 2018 in Review

Clough Capital Partners sold out of Clovis Oncology, Inc. (CLVS) in Q2 2018, closing a stake of 106,335 shares — an estimated $5.61M sold.

Clough Capital Partners first reported a position in CLVS in Q3 2016 and held it in 7 quarters. The position peaked at $10.5M in Q4 2017. 210 funds tracked by Wall St. Rank hold CLVS as of Q2 2018.

  • Clough Capital Partners reported no remaining Clovis Oncology, Inc. position as of Q2 2018 after selling out during the quarter.
  • Clough Capital Partners sold 106,335 Clovis Oncology, Inc. shares in Q2 2018, an estimated $5.61M.
  • Clough Capital Partners first reported a position in Clovis Oncology, Inc. in Q3 2016 and held it in 7 quarters.
  • Clough Capital Partners's Clovis Oncology, Inc. position peaked at $10.5M in Q4 2017.
  • 210 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2018.

Based on Clough Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.